CanSino Biologics Inc. (OTCMKTS:CASBF) Short Interest Update

CanSino Biologics Inc. (OTCMKTS:CASBF) was the recipient of a significant decline in short interest during the month of January. As of January 15th, there was short interest totalling 10,800 shares, a decline of 46.0% from the December 31st total of 20,000 shares. Based on an average daily volume of 400 shares, the short-interest ratio is currently 27.0 days.

CanSino Biologics Price Performance

Shares of OTCMKTS CASBF remained flat at C$3.37 during midday trading on Thursday. CanSino Biologics has a twelve month low of C$1.86 and a twelve month high of C$4.35. The firm has a 50-day moving average of C$3.81 and a 200-day moving average of C$3.18.

About CanSino Biologics

CanSino Biologics Inc develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N.